CRISPR Breakthrough: UC Berkeley Gene Editing Trial Achieves 95% Symptom Reduction in Sickle Cell Patients
UC Berkeley's CRISPR trial for sickle cell disease achieves 95% symptom reduction,…
CRISPR Breakthrough: Gene Editing Cures Rare Muscular Dystrophy in Landmark Human Trial at UC Berkeley
UC Berkeley's CRISPR trial has cured a rare muscular dystrophy in patients,…
CRISPR 2.0 Achieves Historic First: Complete Cure for Rare Genetic Disease in Human Trial
UC Berkeley scientists achieve the first complete cure for rare OTCD using…
